3 causes Bernstein strategists are bullish on the EU pharma sector into 2025 By Investing.com
Investing.com -- Bernstein analysts are optimistic in regards to the European pharmaceutical sector…
Gilead, LEO Pharma associate to develop applications for inflammatory ailments By Reuters
(Reuters) - Gilead Sciences (NASDAQ:) mentioned on Saturday that it entered right…
Transactions in Zealand Pharma shares and/or associated securities by individuals discharging managerial obligations and/or their carefully related individuals By Investing.com
Firm announcement “ No. 53 / 2024 Transactions in Zealand Pharma (NASDAQ:)…
RAMM Pharma Corp. Gives Replace on Litigation By Investing.com
Not for Dissemination within the US or via US Newswire Providers TORONTO,…
Verona Pharma CFO Mark Hahn sells shares price $2.3 million By Investing.com
Mark W. Hahn, Chief Monetary Officer of Verona Pharma PLC (NASDAQ:), has…
US Supreme Courtroom rejects ‘Pharma Bro’ Martin Shkreli’s attraction of penalties By Reuters
By Jonathan Stempel (Reuters) - The U.S. Supreme Courtroom declined on Monday…
Moberg Pharma lowers expectations on main endpoint in ongoing section 3 trial following information in a subset of sufferers By Investing.com
STOCKHOLM, Sept. 13, 2024 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) broadcasts…
Innate Pharma Pronounces Convention Name and Webcast for First Half 2024 Monetary Outcomes and Business Replace By Investing.com
MARSEILLE, France--(BUSINESS WIRE)--Regulatory Information: Innate Pharma SA (OTC:) (Euronext Paris: IPH; Nasdaq:…
FSD Pharma Declares Share Consolidation and Title Change By Investing.com
Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - FSD Pharma Inc. (NASDAQ:…
aTYR Pharma director Paul Schimmel buys $184k in firm shares By Investing.com
In a current sequence of transactions, Paul Schimmel, a director at aTYR…
